Background: Many studies have reported beneficial effects from the application of near-infrared (NIR) light photobiomodulation (PBM) to the body, and one...
Background: Bright light therapy has been shown to have antidepressant and anxiolytic effects in humans. Objective: The antidepressant and anxiolytic effects of...
Background and objective: The application of transcranial low-level light/laser therapy (tLLLT) in the range of red to near-infrared (NIR) spectrum for...
Importance: Limitations of current antidepressants highlight the need to identify novel treatments for major depressive disorder. A prior open trial found...
Major depressive disorder (MDD) is one of the leading forms of psychiatric disorders, characterized by aversion to mobility, neurotransmitter deficiency,...
Background: Low-level light therapy (LLLT) with transcranial laser is a non-invasive form of neuroenhancement shown to regulate neuronal metabolism and cognition....
We examined the use of near-infrared and red radiation (photobiomodulation, PBM) for treating major depressive disorder (MDD). While still experimental,...
Background: The treatment of depression has been hampered by low efficacy of antidepressant medications and safety concerns with alternative modalities. Recent...
Background: Photobiomodulation (PBM) with red and near-infrared light (NIR) -also known as Low-Level Light Therapy-is a low risk, inexpensive treatment-based on...